Hemogenyx Pharmaceuticals (UK) Market Value
| HEMO Stock | 370.05 7.60 2.10% |
| Symbol | Hemogenyx |
Hemogenyx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemogenyx Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemogenyx Pharmaceuticals.
| 07/28/2024 |
| 01/24/2025 |
If you would invest 0.00 in Hemogenyx Pharmaceuticals on July 28, 2024 and sell it all today you would earn a total of 0.00 from holding Hemogenyx Pharmaceuticals PLC or generate 0.0% return on investment in Hemogenyx Pharmaceuticals over 180 days. Hemogenyx Pharmaceuticals is related to or competes with Cairo Communication, Cardinal Health, Inspiration Healthcare, Verizon Communications, Naturhouse Health, Universal Health, and Induction Healthcare. Hemogenyx Pharmaceuticals is entity of United Kingdom More
Hemogenyx Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemogenyx Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemogenyx Pharmaceuticals PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 36.81 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.06 |
Hemogenyx Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemogenyx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemogenyx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Hemogenyx Pharmaceuticals historical prices to predict the future Hemogenyx Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | 0.4923 |
Hemogenyx Pharmaceuticals Backtested Returns
Hemogenyx Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0563, which attests that the entity had a -0.0563 % return per unit of risk over the last 3 months. Hemogenyx Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hemogenyx Pharmaceuticals' Risk Adjusted Performance of (0.03), standard deviation of 7.08, and Market Risk Adjusted Performance of 0.5023 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.74, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Hemogenyx Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Hemogenyx Pharmaceuticals is likely to outperform the market. At this point, Hemogenyx Pharmaceuticals has a negative expected return of -0.38%. Please make sure to check out Hemogenyx Pharmaceuticals' maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Hemogenyx Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.29 |
Weak reverse predictability
Hemogenyx Pharmaceuticals PLC has weak reverse predictability. Overlapping area represents the amount of predictability between Hemogenyx Pharmaceuticals time series from 28th of July 2024 to 26th of October 2024 and 26th of October 2024 to 24th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemogenyx Pharmaceuticals price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Hemogenyx Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 4920.8 |
Hemogenyx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Hemogenyx Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemogenyx Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Hemogenyx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Hemogenyx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hemogenyx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemogenyx Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemogenyx Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemogenyx Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Hemogenyx Pharmaceuticals Lagged Returns
When evaluating Hemogenyx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemogenyx Pharmaceuticals stock have on its future price. Hemogenyx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemogenyx Pharmaceuticals autocorrelation shows the relationship between Hemogenyx Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Hemogenyx Pharmaceuticals PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.